Comparative analysis of permeome genes and drug resistance in Colombia
Colombia is among the countries with the highest malaria burden outside of Africa, and one of the least successful in reducing case numbers, with approximately 100,000 cases per year. The emergence and evolution of antimalarial resistance started approximately 50 years ago, however this problem is poorly understood and no whole genome sequences are yet available for Colombian P. falciparum parasites. This project aims to use sequence data from P. falciparum parasites from the Colombian Pacific region, the predominant area for falciparum malaria in the country, to identify genomic regions with strong evidence for recent selection with a particular focus on variation in permeome drug transporters, potential candidates in the mechanism of action of multidrug resistance.
Summary
- 16 Samples
- 4 Locations
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Locations
Cauca
Summary
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Choco
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Nariño
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers
Valle del Cauca
Samples/Year
QC Pass
Samples that passed Whole-Genome Sequencing Quality Control (QC)
Resistance
Predicted resistance status for main antimalarial drug treatments from molecular markers